Skip to main content
Top

Current Diabetes Reports

Issue 12/2014

Content (11 Articles)

Pathogenesis of Type 2 Diabetes and Insulin Resistance (RM Watanabe, Section Editor)

Glucagon and Type 2 Diabetes: the Return of the Alpha Cell

Asger Lund, Jonatan I. Bagger, Mikkel Christensen, Filip K. Knop, Tina Vilsbøll

Pathogenesis of Type 2 Diabetes and Insulin Resistance (RM Watanabe, Section Editor)

Bone as an Endocrine Organ Relevant to Diabetes

Sarah L. Booth, Amanda J. Centi, Caren Gundberg

Open Access Lifestyle Management to Reduce Diabetes/Cardiovascular Risk (EM Venditti, Section Editor)

Lifestyle Interventions to Reduce Diabetes and Cardiovascular Disease Risk Among Children

Dorothy J. Van Buren, Tiffany L. Tibbs

Lifestyle Management to Reduce Diabetes/Cardiovascular Risk (EM Venditti, Section Editor)

Community Health Worker Interventions for Latinos With Type 2 Diabetes: a Systematic Review of Randomized Controlled Trials

Tariana V. Little, Monica L. Wang, Eida M. Castro, Julio Jiménez, Milagros C. Rosal

Transplantation (A Pileggi, Section Editor)

Stem Cell Therapy to Treat Heart Ischaemia: Implications for Diabetes Cardiovascular Complications

Abbas Ali Qayyum, Anders Bruun Mathiasen, Jens Kastrup

Pathogenesis of Type 1 Diabetes (A Pugliese, Section Editor)

Interleukin 2 in the Pathogenesis and Therapy of Type 1 Diabetes

Michelle Rosenzwajg, Guillaume Churlaud, Agnès Hartemann, David Klatzmann

Pathogenesis of Type 1 Diabetes (A Pugliese, Section Editor)

Extracellular Matrix Components in the Pathogenesis of Type 1 Diabetes

Marika Bogdani, Eva Korpos, Charmaine J. Simeonovic, Christopher R. Parish, Lydia Sorokin, Thomas N. Wight

Diabetes Epidemiology (NM Maruthur, Section Editor)

Type 2 Diabetes Pharmacoepidemiology Update 2014: Safety Versus Efficacy

Sonal Singh

Microvascular Complications—Neuropathy (D Ziegler, Section Editor)

The Charcot Foot as a Complication of Diabetic Neuropathy

Janice V. Mascarenhas, Edward B. Jude

Genetics (AP Morris, Section Editor)

Glucokinase MODY and Implications for Treatment Goals of Common Forms of Diabetes

Ramzi A. Ajjan, Katharine R. Owen

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine